February 2, 2026

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 49.93% Upside in the Healthcare Sector

Encompass Health Corporation (NYSE: EHC) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $9.52 billion, Encompass Health..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring the 27% Upside Potential for Investors

AptarGroup, Inc. (NYSE: ATR), a leader in the field of drug delivery, consumer product dispensing, and active material science solutions, stands at an intriguing juncture for investors. With a current..

Waters Corporation (WAT) Stock Analysis: Navigating a 12.37% Potential Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT), a notable player in the Healthcare sector specializing in Diagnostics & Research, presents a compelling opportunity for investors with its current market dynamics and potential upside...

Waystar Holding Corp. (WAY) Stock Analysis: A 76.6% Potential Upside in the Healthcare Payment Solutions Market

Waystar Holding Corp. (NASDAQ: WAY) is drawing significant attention from investors due to its robust potential upside and dominant position in the healthcare payment solutions market. With a market capitalization..

Tungsten prices hit record highs as supply realigns

Tightening supply and strong demand are driving tungsten prices higher, creating a clear opportunity for investors in critical raw materials...

Tenet Healthcare Corporation (THC) Stock Analysis: Potential 25.56% Upside Amid Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, stands out in the medical care facilities industry with a significant market cap of $16.72 billion. As..

Qiagen N.V. (QGEN) Stock Analysis: Diagnostic Powerhouse with a 6.1% Revenue Growth

Qiagen N.V. (NYSE: QGEN), a key player in the healthcare sector, specializes in diagnostics and research. Headquartered in Venlo, the Netherlands, the company has carved out a significant niche in..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unpacking the 16.69% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) stands at the intersection of innovation and opportunity in the healthcare sector, boasting a market capitalization of $36.05 billion. As a key player in..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 12.78% Potential Upside Amid Healthcare Sector Dynamics

Align Technology, Inc. (NASDAQ: ALGN) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $11.82 billion, the company..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 6.79% Potential Upside in the Healthcare Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing the attention of investors with its promising potential for growth. Headquartered..

Masimo Corporation (MASI) Stock Analysis: Unlocking a 33.80% Potential Upside in the Healthcare Sector

Masimo Corporation (MASI), a formidable player in the healthcare sector, is renowned for its innovative medical devices and patient monitoring technologies. Headquartered in Irvine, California, Masimo’s market capitalization stands at..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a Competitive Genomics Landscape with Resilient Growth

For investors keen on the intersection of healthcare and cutting-edge technology, Illumina, Inc. (NASDAQ: ILMN) offers a compelling case. As a leader in the Diagnostics & Research industry, Illumina plays..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 18.75% Upside in the Oncology Sector

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry, is making waves in the healthcare sector with its innovative approach to cancer treatment. Based in Basel, Switzerland, this..

Insmed Incorporated (INSM) Stock Analysis: Exploring a Promising 37% Upside with Strong Buy Ratings

Investors eyeing the biotechnology sector should take a closer look at Insmed Incorporated (NASDAQ: INSM), a healthcare innovator focusing on treatments for serious and rare diseases. With a compelling potential..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Strong Revenue Growth Amidst Market Volatility

Medpace Holdings, Inc. (NASDAQ: MEDP) is making waves in the healthcare sector with its robust revenue growth and strategic positioning in the diagnostics and research industry. The Cincinnati-based company, which..

Solventum Corporation (SOLV) Stock Analysis: Exploring a 15.95% Upside Potential in Healthcare Innovation

Solventum Corporation (NASDAQ: SOLV) is carving out a significant niche in the healthcare sector with its innovative range of medical instruments and supplies. As the company continues to expand its..

Royalty Pharma (RPRX) Stock Analysis: Analysts See 15% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) has carved out a distinctive niche in the biotechnology sector, standing as a key player in the acquisition of biopharmaceutical royalties. With a market capitalization..

Gilead Sciences, Inc. (GILD)

⚠️ No article content returned.

..

Viatris Inc. (VTRS) Stock Analysis: Navigating Challenges with a Solid Dividend Yield

Viatris Inc. (NASDAQ: VTRS) presents a complex investment case within the healthcare sector. As a prominent player in the drug manufacturing industry, particularly in the specialty and generic segments, Viatris..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Evaluating the 7.9% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA) remains a compelling player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Tel Aviv-Yafo, Israel, Teva has..

Search

Funds

February 2, 2026

Tungsten prices hit record highs as supply realigns

Tightening supply and strong demand are driving tungsten prices higher, creating a clear opportunity for investors in critical raw materials...
Search

Funds

February 2, 2026

FTSE 100

Funds